Alcon Inc. (ALC)
NYSE: ALC · Real-Time Price · USD
94.57
-1.20 (-1.25%)
Mar 31, 2025, 9:39 AM EDT - Market open

Company Description

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide.

It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures.

Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert.

In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, grieshaber, MIVS instruments, scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure.

Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers.

The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001.

Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Alcon Inc.
Alcon logo
Country Switzerland
Founded 1945
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 25,599
CEO David Endicott

Contact Details

Address:
Chemin de Blandonnet 8, Vernier
Geneva, 1214
Switzerland
Phone 41 589 112 110
Website alcon.com

Stock Details

Ticker Symbol ALC
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001167379
CUSIP Number H01301128
ISIN Number CH0432492467
Employer ID 98-0205094
SIC Code 3851

Key Executives

Name Position
David J. Endicott Chief Executive Officer and Director
Timothy C. Stonesifer Senior Vice President and Chief Financial Officer
Ian Bell Senior Vice President and Chief Operating Officer
Margaret Buckley Chief Accounting Officer
Dr. Franck Leveiller SVice President of Global Research and Development and Chief Scientific Officer
Muru Murugappan Senior Vice President and Chief Information and Transformation Officer
Royce R. Bedward J.D. Senior Vice President, General Counsel and Corporate Secretary
Kimberly Martin Senior Vice President, Chief Human Resources Officer and Corporate Communications
Leon Sergio Duplan Fraustro Senior Vice President and President of Americas
Laurent Attias SVice President of Corporate Strategy, Business Development and Licensing (BD&L), M&A

Latest SEC Filings

Date Type Title
Mar 3, 2025 144 Filing
Feb 28, 2025 144 Filing
Feb 27, 2025 144 Filing
Feb 25, 2025 6-K Report of foreign issuer
Feb 25, 2025 20-F Annual and transition report of foreign private issuers
Feb 25, 2025 6-K Report of foreign issuer
Nov 12, 2024 6-K Report of foreign issuer
Sep 12, 2024 144 Filing
Sep 12, 2024 144 Filing
Sep 9, 2024 144 Filing